CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib

Clinical trial NCT04676334 · COMPLETED

Trial details

NCT number: NCT04676334
Sponsor: pharmaand GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Castration-Resistant Prostate Cancer Ovarian Cancer Epithelial Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer Other Solid Tumor

Start date: 2021-03-22
Primary completion: 2023-03-08
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.